Angiotensin converting enzyme inhibitors and progressive renal insufficiency. Current experience and future directions.

STUDY OBJECTIVE To review the rationale for using angiotensin converting enzyme (ACE) inhibitors in progressive renal disease, and to evaluate the experience with these agents in patients with hypertension and renal insufficiency. DATA IDENTIFICATION Experimental and clinical studies published from January 1977 to November 1988 were identified by searching the literature and by extensive hand searching of bibliographies of identified articles. STUDY SELECTION Experimental studies of glomerular function during therapy with ACE inhibitors or other antihypertensive regimens were reviewed. Series using ACE inhibitors for treating hypertensive patients with renal disease were evaluated and reports of adverse events were studied. RESULTS OF DATA SYNTHESIS Experimentally, ACE inhibitors seem to decrease glomerular injury by reducing both systemic and glomerular hypertension. Clinically, ACE inhibitors reduce systemic blood pressure in hypertensive patients with diabetic and nondiabetic renal disease without causing dramatic changes in glomerular filtration rate or renal blood flow. Most studies of nondiabetic renal insufficiency suggest that proteinuria is reduced in most patients. However, no long-term controlled study on the effect of ACE inhibitors on the progression rate of nondiabetic renal disease has been completed. ACE inhibitors have not yet been approved by the Food and Drug Administration (FDA) for treating or preventing progressive renal disease. Such use would therefore be considered "innovative" therapy. CONCLUSIONS ACE inhibitors are tolerated by azotemic patients, although transient reductions in renal function can occur. Patients with bilateral renal insufficiency or low cardiac output are at increased risk for developing reversible acute renal insufficiency. Hyperkalemia may occur, particularly in patients with diabetes or severe renal insufficiency. In many patients with renal disease, ACE inhibitors dramatically reduce proteinuria, but whether they also reduce the rate of progression of renal disease remains unproved.

[1]  T. Meyer,et al.  Increased single-nephron protein excretion after renal ablation in nephrotic rats. , 1988, The American journal of physiology.

[2]  S. Klahr,et al.  Effect of heparin on the glomerular structure and function of remnant nephrons. , 1988, Kidney international.

[3]  W. Keane,et al.  Efficacy and renal effects of enalapril therapy for hypertensive patients with chronic renal insufficiency. , 1988, Archives of internal medicine.

[4]  L. Antiga,et al.  Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. , 1988, The American journal of medicine.

[5]  B. Kasiske,et al.  Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. , 1988, Kidney international.

[6]  D. Harris,et al.  Glomerular hemodynamic adaptations in remnant nephrons: effects of verapamil. , 1988, The American journal of physiology.

[7]  G. Faich,et al.  The importance of adverse reaction reporting by physicians. Suprofen and the flank pain syndrome. , 1988, JAMA.

[8]  D. Harris,et al.  Remnant kidney hypermetabolism and progression of chronic renal failure. , 1988, The American journal of physiology.

[9]  B. Kasiske,et al.  Pharmacologic Treatment of Hyperlipidemia Reduces Glomerular Injury in Rat 5/6 Nephrectomy Model of Chronic Renal Failure , 1988, Circulation research.

[10]  S. Klahr,et al.  N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. , 1988, The Journal of clinical investigation.

[11]  B. Kasiske,et al.  Hyperlipidemia and the progression of renal disease. , 1988, The American journal of clinical nutrition.

[12]  B. Kasiske,et al.  Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. , 1988, American journal of nephrology.

[13]  B. Brenner,et al.  Chronic glucocorticoid therapy amplifies glomerular injury in rats with renal ablation. , 1987, The Journal of clinical investigation.

[14]  J. Bauer,et al.  Renal protective effect of strict blood pressure control with enalapril therapy. , 1987, Archives of internal medicine.

[15]  D. de Zeeuw,et al.  Reduction of proteinuria by angiotensin converting enzyme inhibition. , 1987, Kidney international.

[16]  R. Levine FDA's new rule on treatment use and sale of investigational new drugs. , 1987, IRB.

[17]  M. Marre,et al.  Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. , 1987, British medical journal.

[18]  R. Blantz,et al.  An evaluation of the development of experimental membranous nephropathy. , 1987, Kidney international.

[19]  Lewis Ej Glomerular abnormalities in patients receiving angiotensin converting enzyme inhibitor therapy. , 1987 .

[20]  J. Ménard,et al.  Renal damage induced in the clipped kidney of one-clip, two-kidney hypertensive rats during normalization of blood pressure by converting enzyme inhibition. , 1987, Kidney international. Supplement.

[21]  H. Aynedjian,et al.  Evidence against increased glomerular pressure initiating diabetic nephropathy. , 1987, Kidney international.

[22]  B. Brenner,et al.  Reversing glomerular hypertension stabilizes established glomerular injury. , 1987, Kidney international.

[23]  L. Dworkin,et al.  Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy. , 1987, Kidney international.

[24]  M. Marre,et al.  Effects of Enalapril in Insulin-Dependent Diabetic Subjects With Mild to Moderate Uncomplicated Hypertension , 1987, Diabetes Care.

[25]  F. Cambien,et al.  Body Mass, Blood Pressure, Glucose, and Lipids: Does Plasma Insulin Explain Their Relationships? , 1987, Arteriosclerosis.

[26]  D. Harris,et al.  Verapamil protects against progression of experimental chronic renal failure. , 1987, Kidney international.

[27]  N. Bobadilla,et al.  Effect of captopril and hydrochlorothiazide on glomerular haemodynamics and histological damage in Goldblatt hypertension with partial renal ablation. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[28]  J. Bauer,et al.  Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction. , 1986, Archives of internal medicine.

[29]  T. Hostetter,et al.  Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction. , 1986, The Journal of clinical investigation.

[30]  J. Wikstrand,et al.  Left ventricular function before and after kidney transplantation. A prospective study in patients with juvenile-onset diabetes mellitus. , 1986, European heart journal.

[31]  A. Donker,et al.  Effects of nonsteroidal anti-inflammatory drugs on proteinuria. , 1986, The American journal of medicine.

[32]  G. Nyberg,et al.  Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. , 1986, British medical journal.

[33]  H. Parving,et al.  Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. , 1986, British medical journal.

[34]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[35]  B. Brenner,et al.  Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. , 1986, The Journal of clinical investigation.

[36]  J. Ménard,et al.  Effects of antihypertensive treatment in one-clip, two kidney hypertension in rats. , 1986, Kidney international.

[37]  J. Weening,et al.  Genetic factors in focal segmental glomerulosclerosis. , 1986, Kidney international.

[38]  C. Johnston,et al.  PRESERVATION OF RENAL FUNCTION IN THE RAT REMNANT KIDNEY MODEL OF CHRONIC RENAL FAILURE BY BLOOD PRESSURE REDUCTION , 1986, Clinical and experimental pharmacology & physiology.

[39]  D. Harris,et al.  Phosphate depletion arrests progression of chronic renal failure independent of protein intake. , 1986, Kidney international.

[40]  R. Dibianco Adverse Reactions with Angiotensin Converting Enzyme (ACE) Inhibitors , 1986, Medical toxicology.

[41]  B. Joffe,et al.  The management of acute severe asthma. , 1986, Postgraduate medical journal.

[42]  S. Giannini,et al.  Captopril in the treatment of hypertension in type I and type II diabetic patients. , 1985, Postgraduate medical journal.

[43]  B. Clarke,et al.  The effect of captopril on blood pressure and glucose tolerance in hypertensive non-insulin dependent diabetics. , 1986, Postgraduate medical journal.

[44]  A. Hurtado,et al.  Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus. , 1986, Postgraduate medical journal.

[45]  Y. Taguma,et al.  Effect of captopril on heavy proteinuria in azotemic diabetics. , 1985, The New England journal of medicine.

[46]  A. Wing,et al.  Hypertension and Cardiovascular Risk Factors in Hemodialyzed Diabetic Patients , 1985, Hypertension.

[47]  C. Mogensen,et al.  Blood Pressure Changes and Renal Function in Incipient and Overt Diabetic Nephropathy , 1985, Hypertension.

[48]  B. Brenner,et al.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Neugarten,et al.  Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy. , 1985, Kidney international.

[50]  B. Brenner,et al.  Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. , 1985, The Journal of clinical investigation.

[51]  S. Linas,et al.  Mechanism of decreased vascular responsiveness to angiotensin ii in early 2 kidney 1 clip hypertensive rats , 1985 .

[52]  A. Novick,et al.  Critical perfusion pressure for renal function in patients with bilateral atherosclerotic renal vascular disease. , 1985, Annals of internal medicine.

[53]  G. Dreslinski,et al.  Captopril in hypertension; seven years later. , 1985, Journal of cardiovascular pharmacology.

[54]  W. V. van Son,et al.  Effect of captopril on blood pressure and renal function in patients with transplant renal artery stenosis. , 1985, Nephron.

[55]  S. Klahr,et al.  Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Christiansen Js On the pathogenesis of the increased glomerular filtration rate in short-term insulin-dependent diabetes. , 1984 .

[57]  H. Mulec,et al.  Captopril treatment of hypertension and renal failure in systemic lupus erythematosus. , 1984, Nephron.

[58]  C. Johnston,et al.  ANGIOTENSIN CONVERTING ENZYME INHIBITION IN RENOVASCULAR HYPERTENSION: FREQUENCY OF REVERSIBLE RENAL FAILURE , 1984, The Lancet.

[59]  R J Jarrett,et al.  Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. , 1983, British medical journal.

[60]  D. Adu,et al.  HYPERKALAEMIA IN CYCLOSPORIN-TREATED RENAL ALLOGRAFT RECIPIENTS , 1983, The Lancet.

[61]  H. Parving,et al.  EARLY AGGRESSIVE ANTIHYPERTENSIVE TREATMENT REDUCES RATE OF DECLINE IN KIDNEY FUNCTION IN DIABETIC NEPHROPATHY , 1983, The Lancet.

[62]  T. Usherwood,et al.  Factors related to first dose hypotensive effect of captopril: prediction and treatment. , 1983, British medical journal.

[63]  N. Madias,et al.  Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. , 1983, The New England journal of medicine.

[64]  R. Bilous,et al.  Monitoring glomerular function in diabetic nephropathy. A prospective study. , 1983, The American journal of medicine.

[65]  L. Navar,et al.  Angiotensin-mediated alterations in nephron function in Goldblatt hypertensive rats. , 1982, The American journal of physiology.

[66]  J. Whitworth,et al.  Repeated renal failure with use of captopril in a cystinotic renal allograft recipient. , 1982, British medical journal.

[67]  C. Mogensen Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy , 1982, British medical journal.

[68]  B. Brenner,et al.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. , 1982, The New England journal of medicine.

[69]  D. Vidt,et al.  RENAL GLYCOSURIA AND AZOTAEMIA AFTER ENALAPRIL MALEATE (MK-421) , 1982, The Lancet.

[70]  L. Balant,et al.  The kidney in maturity onset diabetes mellitus: a clinical study of 510 patients. , 1982, Kidney international.

[71]  B. Brenner,et al.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. , 1981, The American journal of physiology.

[72]  B. Brenner,et al.  Glomerular hemodynamics in experimental diabetes mellitus. , 1981, Kidney international.

[73]  M. Aurell,et al.  Reference values for 51Cr-EDTA clearance as a measure of glomerular filtration rate. , 1981, Scandinavian journal of clinical and laboratory investigation.

[74]  M. Dunn,et al.  Renal effects of drugs that inhibit prostaglandin synthesis. , 1980, Kidney international.

[75]  J. Weening,et al.  IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL , 1980, The Lancet.

[76]  P. Bennett,et al.  Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. , 1980, The New England journal of medicine.

[77]  A. Alfrey,et al.  Preservation of renal function in experimental glomerulonephritis. , 1980, Kidney international.

[78]  J. Rowe,et al.  Adrenergic modulation of extrarenal potassium disposal. , 1980, The New England journal of medicine.

[79]  K. Phelps,et al.  Heparin-induced hyperkalemia: report of a case. , 1980, Nephron.

[80]  M. A. Johnson,et al.  Single-nephron pressures, flows, and resistances in hypertensive kidneys with nephrosclerosis. , 1977, Kidney international.

[81]  R. Temple Legal Implications of the Package Insert , 1974 .

[82]  L. Lasagna Some ethical problems in clinical investigation. , 1968, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.